Neuropeptide Y: a promising candidate in affective disorders
First published: 23 March 2012
No abstract is available for this article.
References
- 1
Wu G,
Feder A,
Wegener G et al.
Central functions of neuropeptide Y in mood and anxiety disorders.
Expert Opin Ther Targets
2011; 15: 1317–1331.
- 2
Koefoed P,
Woldbye DPD,
Hansen TvO et al.
Association of the leucine-7 to proline-7 variation in the signal sequence of neuropeptide Y with major depression.
Acta Neuropsychiatr
2011
(this issue).
- 3
Heilig M,
Zachrisson O,
Thorsell A et al.
Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism.
J Psychiatr Res
2004; 38: 113–121.
- 4
Sjöholm LK,
Melas PA,
Forsell Y,
Lavebratt C.
PreproNPY Pro7 protects against depression despite exposure to environmental risk factors.
J Affect Disord
2009; 118: 124–130.
- 5
Lin PI,
Vance JM,
Pericak-Vance MA,
Martin ER.
No gene is an island: the flip-flop phenomenon.
Am J Hum Genet
2007; 80: 531–538.
- 6
Amstadter AB,
Koenen KC,
Ruggiero KJ et al.
NPY moderates the relation between hurricane exposure and generalized anxiety disorder in an epidemiologic sample of hurricane-exposed adults.
Depress Anxiety
2010; 27: 270–275.
- 7
Domschke K,
Dannlowski U,
Hohoff C et al.
Neuropeptide Y (NPY) gene: impact on emotional processing and treatment response in anxious depression.
Eur Neuropsychopharmacol
2010; 20: 301–309.
- 8
Domschke K,
Hohoff C,
Jacob C et al.
Chromosome 4q31-34 panic disorder risk locus: association of neuropeptide Y receptor Y5 variants.
Am J Med Genet B Neuropsychiatr Genet
2008; 147: 510–516.
- 9
Crespi F.
Influence of neuropeptide Y and antidepressants upon cerebral monoamines involved in depression: an in vivo electrochemical study.
Brain Res
2011; 1407: 27–37.
